{"id":"W2092480028","doi":"10.1186/1741-7015-10-161","title":"Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment","year":2012,"lang":"en","type":"review","venue":"BMC Medicine","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Sociedad Española de Oncología Médica; Conquer Cancer Foundation","keywords":"Crizotinib; Medicine; PI3K/AKT/mTOR pathway; Anaplastic lymphoma kinase; Cancer research; Receptor tyrosine kinase; Kinase; Tyrosine kinase; Clinical trial; Cancer; Gene isoform; Pharmacology; Signal transduction; Oncology; Biology; Lung cancer; Internal medicine; Receptor; Cell biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006879749,0.0004777181,0.00165274,0.0000707125,0.00005465287,0.000003123499,0.0002781065,0.0005303529,0.00009027514],"category_scores_gemma":[0.0001777751,0.0003209108,0.0004840115,0.0001019062,0.0001740101,0.000001763953,0.00007701129,0.0001124605,0.000007013516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001616757,"about_ca_system_score_gemma":0.00169935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002646828,"about_ca_topic_score_gemma":0.00008827897,"domain_scores_codex":[0.9973138,0.0001213982,0.001405913,0.0005784322,0.0002229088,0.0003575303],"domain_scores_gemma":[0.998129,0.0001859326,0.0007770409,0.0005555062,0.0001401177,0.000212389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005582109,0.0001465906,0.0004144924,0.006464491,0.0004608137,7.015325e-7,0.00005263312,6.736826e-7,0.000174897,0.00000575354,0.003456889,0.9887663],"study_design_scores_gemma":[0.001101315,0.0006387692,0.00001835264,0.005876569,0.001367279,0.000003680001,0.00001129798,9.214159e-7,0.004671726,0.000001339277,0.9860021,0.0003066441],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002991769,0.9950665,0.0009301311,0.00001481182,0.002216712,0.001265617,0.00008768979,0.00001084547,0.0001084873],"genre_scores_gemma":[0.0001738729,0.9872392,0.004791308,0.00005171082,0.005063921,0.00100111,0.00070652,0.00007942379,0.000892956],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9884596,"threshold_uncertainty_score":0.9999243,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.171878412395407,"score_gpt":0.4533208998068582,"score_spread":0.2814424874114513,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}